This content is machine translated ACC Congress in San Diego “Universal antidote” of the future? An antidote to Factor Xa inhibitors is making great progress in clinical trials: Andexanet alfa. New results were presented at the American College of Cardiology Congress in San Diego: According…
View Post 5 min This content is machine translated 18th Annual Meeting of the Swiss Cerebrovascular Society Cerebral hemorrhagic complications during anticoagulation – how to proceed? Intracranial hemorrhage is one of the most feared complications of oral anticoagulant therapy. At the annual meeting of the Swiss Cerebrovascular Society in Geneva, a lecture was dedicated to this…
